Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07584590

A Brief Intervention by Nurses to Reduce the Prescribing of Occluded Peripheral Venous Catheters in the Emergency Department

Peripheral venous catheters are frequently inserted in hospitals, with approximately 25 million placed annually in France (HAS data, 2005). The occluded peripheral venous catheter with extension tubing has become the standard in some emergency departments, offering advantages such as patient mobility, the ability to perform repeated blood draws, and the administration of intravenous medications. A 2018 meta-analysis revealed that one in three devices was unnecessary. The placement of a occluded peripheral venous is associated with a more painful insertion, higher cost, and an increased risk of infection and thromboembolism, and blood samples obtained via the occluded peripheral venous catheter are more often hemolyzed than those obtained by direct venipuncture.

Communication between physicians and nurses is essential to ensure optimal patient care. A brief intervention by the nurse when a physician prescribes a occluded peripheral venous catheter can help clarify the appropriateness of this prescription, which could lead to reduced pain for the patient, time savings for healthcare providers, and material cost savings for the hospital.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

CHU Amiens, Amiens, France

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients assigned a triage score of 3A, 3B, or 4 according to the French triage scale, or 3 or 4 according to the CIMU triage scale, by the triage nurse
  • Patients with a blood draw order involving the placement of an occluded catheter
  • Age 18 years or older
  • Patients who have read and understood the information sheet
  • Patients who have given their verbal consent to participate in the study
  • Patients enrolled in a social security program

Exclusion criteria

  • Patients admitted to the emergency department with a pre-existing intravenous line
  • Patients treated by the Mobile Emergency and Resuscitation Unit outside the hospital
  • Patients with a blocked catheter who did not undergo an initial blood draw
  • Patient with known neurocognitive disorders incompatible with informed consent
  • Pregnant or breastfeeding woman
  • Patient under legal guardianship (guardianship or conservatorship) or patient deprived of liberty
  • Patient refusing to participate in the study
  • Patient participating in another interventional research study

Treatment and study plan

question for the prescriber

Other

Once the nurse has received the doctor's order for a blood draw with a KTO, she will ask the prescribing physician: Is the KTO being prescribed for: the administration of medication? The injection of a contrast agent? A second blood draw? For each question, there are three possible answers: Yes? No? Maybe?

Primary outcomes

  1. the proportion of obturator catheters placed improperly

    Time frame: day 1

    Questions for the prescriber

Secondary outcomes

  1. Correlation between the physician's final decision and nurse activity

    Time frame: day 1

    Correlation between the physician's final decision and the performance of a repeat biopsy, the administration of contrast dye, or the administration of intravenous treatment

  2. Use of the numerical pain scale during obturator catheter placement

    Time frame: at the end of procedure (assessed up to 20 minutes)

    pain during obturator catheter placement

  3. Micro-costing analysis

    Time frame: at the end of procedure (assessed up to 20 minutes)

    Micro-costing analysis of the cost of a standard venous blood draw and a closed-catheter procedure

  4. Types of intravenous medications administered

    Time frame: day 1

    Types of intravenous medications administered and available oral alternatives

  5. Number of orders for obturator catheters

    Time frame: day 1

    Number of orders for obturator catheters placement during the initial blood draw for each period throughout the entire enrollment period

Study contacts

Contact information is provided by the study sponsor or research team.

Jessica BORTZMEYER, nurse

CONTACT

[email protected]

02.32.88.89.90 ext. +33

ROUSSEL Mélanie, MD

CONTACT

[email protected]

Sponsors and collaborators

Lead sponsor

University Hospital, Rouen

Other

Registry information

Acronym: PERFEKTO

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
May 13, 2026
Registry last updated
May 13, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.